Vardenafil hydrochloride trihydrate topical gel

Drug Profile

Vardenafil hydrochloride trihydrate topical gel

Alternative Names: TR 399; TR-422

Latest Information Update: 03 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Tritech Biopharmaceuticals
  • Class Erectile dysfunction therapies; Imidazoles; Piperazines; Small molecules; Sulfones; Triazines
  • Mechanism of Action Type 5 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Erectile dysfunction
  • Preclinical Pulmonary arterial hypertension

Most Recent Events

  • 20 Apr 2017 Phase-I/II clinical trials in Erectile dysfunction in Taiwan (Topical) (NCT03102398)
  • 19 Apr 2017 Preclinical trials in Pulmonary arterial hypertension (In infants, In children) in Taiwan (Topical) prior to April 2017 (Tritech Biopharmaceuticals pipeline, April 2017)
  • 12 Apr 2017 Chemical structure information added
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top